NAD+ depletion by APO866 in combination with radiation in a prostate cancer model, results from an in vitro and in vivo study

Our studies show that APO866-induced NAD+ depletion enhances radiation responses in tumor cell survival in prostate cancer. However, the in vitro data do not reveal a solid cellular mechanism to exploit further clinical development at this moment.